New multi-million programme to tackle black carbon and protect health

Clean Air Fund’s landmark programme is accelerating action on black carbon, a super pollutant that harms people’s health and drives climate change far beyond its share. With £10m funding from Wellcome, we will drive pioneering research and advocacy to deliver urgent health and climate benefits. Wellcome is supporting Clean Air Fund to drive global action on black carbon with £10m in new funding. Our landmark programme will focus on delivering health and climate gains by supporting research, policy and advocacy efforts to accelerate action where it is most urgently needed.…

Read More

Britons united on mental health, but politics lags behind, polling finds

Britons are far more united on mental health than the political debate suggests, according to polling published today by the Wellcome Trust and More in Common. The findings form the backdrop to the launch of Head On, a new campaign backed by more than 20 organisations, public figures, including Alastair Campbell, and people with lived experience, calling on political leaders to turn that public consensus into action. The message is clear: on one of the country’s biggest health challenges, the public is ahead of Westminster and three quarters of Britons…

Read More

Bill & Melinda Gates Foundation, Wellcome and Mastercard Launch Initiative to Speed Development and Access to Therapies for COVID-19

The Bill & Melinda Gates Foundation, Wellcome and Mastercard have committed up to $125 million in seed funding to speed-up the response to the COVID-19 epidemic by identifying, assessing, developing, and scaling-up treatments. The partners are committed to equitable access, including making products available and affordable in low-resource settings. The COVID-19 Therapeutics Accelerator will play a catalytic role by accelerating and evaluating new and repurposed drugs and biologics to treat patients with COVID-19 in the immediate term, and other viral pathogens in the longer-term. Currently there are no broad-spectrum antivirals…

Read More